Cargando…
Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy
To develop a suitable formulation with high entrapment efficiency, etoposide-loaded poly(lactide-co-glycolide) nanoparticles (NPs) were formulated by single emulsion-solvent evaporation method by changing different formulation parameters such as drug loading, choice of organic solvent and percentage...
Autores principales: | Mitra, Moutushy, Dilnawaz, Fahima, Misra, Ranjita, Harilal, Anju, Verma, Rama Shenkar, Sahoo, Sanjeeb K., Krishnakumar, Subramanian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452038/ https://www.ncbi.nlm.nih.gov/pubmed/26069482 http://dx.doi.org/10.1007/s12645-010-0010-4 |
Ejemplares similares
-
Erratum to: Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy
por: Mitra, Moutushy, et al.
Publicado: (2011) -
Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells
por: Mitra, Moutushy, et al.
Publicado: (2011) -
EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy
por: Mitra, Moutushy, et al.
Publicado: (2012) -
A novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs
por: Mitra, Moutushy, et al.
Publicado: (2012) -
Genome-wide changes accompanying the knockdown of Ep-CAM in retinoblastoma
por: Mitra, Moutushy, et al.
Publicado: (2010)